Itrafresh 200

Itrafresh 200 is a potent antifungal medication marketed by Arozia Care, a pharmaceutical entity focused on “Skin Science for Skin Health.” This product is specifically formulated as a 200mg capsule, containing the active pharmaceutical ingredient Itraconazole, which belongs to the triazole class of antifungal agents. It is designed to combat a broad spectrum of fungal infections that affect the skin, nails, and internal systems.

Pharmaceutical Composition and Potency

The core strength of Itrafresh 200 lies in its high concentration of Itraconazole. While many standard antifungal treatments are available in 100mg dosages, the 200mg variant is often prescribed for more stubborn or systemic infections. Itraconazole works by inhibiting the fungal enzyme cytochrome P450 14$\alpha$-demethylase. This inhibition prevents the conversion of lanosterol to ergosterol, an essential component of the fungal cell membrane. By disrupting the membrane’s integrity, the medication effectively halts the growth of the fungi and eventually leads to the elimination of the infection.

Quality Standards and Certification

Arozia Care emphasizes its commitment to safety and efficacy through multiple international certifications prominently displayed on its branding. Itrafresh 200 is manufactured in facilities that adhere to:

• WHO-GMP: World Health Organization Good Manufacturing Practices, ensuring that products are consistently produced and controlled according to quality standards.
• ISO Certified: Indicating adherence to rigorous quality management systems.
• GMP (Good Manufacturing Practice): Further reinforcing that the manufacturing process minimizes risks involved in pharmaceutical production that cannot be eliminated through testing the final product.

Therapeutic Indications

Itrafresh 200 is primarily used to treat various fungal conditions, including:

1. Dermatophytosis: Common skin infections like Tinea Corporis (ringworm), Tinea Cruris (jock itch), and Tinea Pedis (athlete’s foot).
2. Onychomycosis: Fungal infections of the fingernails or toenails, which often require long-term treatment and higher dosages due to the slow growth of nails.
3. Candidiasis: Yeast infections affecting the skin or mucous membranes.
4. Systemic Mycoses: Deep-seated fungal infections such as aspergillosis, blastomycosis, and histoplasmosis, where a systemic approach is vital.